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Background: In the last decade, multiple studies have been published that analyze the relationship between the risk 
of experiencing biological complications with implants and the presence of certain types of genetic polymorphis-
ms. In the present report, we analyze the controversies that have arisen from this important area of investigation and 
synthesize the most prominent aspects of knowledge related to this possible etiopathogenic relationship. 
Material and Methods: For this review, the biomedical databases PubMed-Medline, SciELO, and DOAJ were 
used. Different search strategies were employed, from which 298 articles initially emerged. After refinement of the 
search, 55 articles published between 2002 and 2018 were finally selected based on relevance. 
Results: In certain population groups, there is evidence to support that about a dozen polymorphisms could in some 
way be related to biological complications in implantology. Indeed, the results may vary according to the ethnic 
origin of the population studied. Most of the published investigations are initial studies reporting small sample 
sizes and utilizing different study group homogenization methods. We are still at a preliminary stage of our un-
derstanding and development with regard to these types of biomarkers. The interesting results identified indicate 
that new investigations will be necessary to eliminate the biases observed in some studies and to homogenize the 
research groups. In order to clarify the controversies surrounding the current knowledge in this field, we believe 
that it will be necessary to employ larger study groups and search for possible synergistic effects between different 
polymorphisms.
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Introduction
Currently, implantology is a predictable and reprodu-
cible alternative for replacing missing teeth. Improve-
ments in the design and physical-chemical properties 
of implants and related treatment protocols have led to 
a drastic reduction in problems with osseointegration, 
which were initially observed in a significant number of 
cases. Indeed, the most recent studies have shown that 
the rate of early failure does not exceed 1-2% of cases 
(1,2). However, modern dental implantology is current-
ly facing a challenge to reduce the increasing rates of 
peri-implant disease (2,3). Despite the discrepancies 
in diagnostic criteria and inclusion in different studies, 
more than 60% of individuals and 30% of implants show 
evidence of the presence of peri-implant mucositis, whi-
le up to 18% of patients and over 9% of the implants 
demonstrate some degree of peri-implantitis (3,4).
Several factors are known to play a role in the com-
plex etiology of peri-implant disease, such as tobacco 
consumption, oral hygiene, the presence of periodontal 
disease, oral biofilm composition, bone quality, certain 
systemic pathologies (e.g., diabetes), implant type, the 
techniques employed for implant placement, prosthesis 
design or transmission of occlusal loads (5-8).
In a straightforward manner, all of these factors act 
through three different pathogenic mechanisms, which 
are: disruption of the balance between the biofilm and 
the patient’s own immune system, overcoming the re-
pair capacity of bone tissue and modifications in implant 
surfaces resulting from corrosion (5-8). Each of these 
mechanisms can stimulate hyperproduction of proin-
flammatory cytokines and increase osteoclastic activity 
in tissues surrounding the implant. These phenomena 
promote rupture of the physiological balance between 
bone apposition and resorption in favor of a greater re-
sorptive activity in the peri-implant bone tissue (4-8).
Of course, these etiopathogenic factors could be directly 
and indirectly conditioned by genetic factors that deter-
mine their magnitude and relevance in each individual. 
They are part of what we call “individual susceptibility” 
and explain the different biological responses observed 
in individuals presenting the same risk factors (5-8).
Epidemiological studies have shown the existence of 
patients having a “certain predisposition” or augmented 
risk of suffering from peri-implant disease. In these pa-
tients, failures tend to cluster or “clump together” (9). 
This observation has made numerous authors ask them-
selves whether such “predisposition” or “greater risk” 
could be, at least in part, genetically conditioned (9,10). 
Another question, which is equally as important if not 
more than the previous one, is whether “predisposition” 
could be detected or quantified. If so, we could know be-
forehand the relative risk of a particular patient to suffer 
from peri-implant disease due to their genetic characte-
ristics or “peculiarities” and proactively establish perso-
nalized diagnostic and therapeutic protocols to reduce its 
prevalence (9,10).
These genetic “peculiarities” are caused by DNA mu-
tations. Some of these mutations are significantly pre-
valent in the population (above 1%), constituting what 
are called “genetic polymorphisms”. For this reason, in 
recent years, several studies have been conducted to try 
to understand the relationship between certain polymor-
phisms and peri-implant disease. The majority of the 
polymorphisms studied affect a single nucleotide and 
are called SNPs (Single Nucleotide Polymorphism). 
Among these, in relation to peri-implant disease, those 
that are present in the genes involved in inflammatory 
responses and regulation of bone metabolism have been 
specifically studied (10).
The role of genetic polymorphisms in different autoim-
mune, neurological and even oncological pathologies 
has been widely studied (11,12). On the contrary, in the 
case of peri-implant disease, there are still few studies 
and the results remain inconclusive. However, the avai-
lable studies are promising and justify additional efforts 
to continue investigating in this field. In this narrative 
review, we try to synthesize and perform a critical analy-
sis on the relationship between genetic polymorphisms, 
peri-implant disease and the risk of early implant failure.
Material and Methods
For this literature review, the biomedical databases Pub-
Med-Medline, SciELO and  DOAJ were used. Different 
search strategies  were employed, resulting from the 
combination of keywords from the MeSH terminology 
dictionary such as: “polymorphism”, “genetic markers”, 
“genetic polymorphism”, “peri-implantitis”, “implant 
failure” and “dental implant”.
Using this initial search strategy, 298 articles were found. 
After the elimination of duplicate articles, followed by 
evaluation and filtering of the remaining articles, 55 re-
levant publications were finally selected, published be-
tween 2002 and 2018 Figure 1.
Results
-Polymorphisms of IL-1 
Cytokines are signaling molecules responsible for in-
tercellular communication that induces the activation 
of specific membrane receptors. Some of their functions 
contribute to control of the inflammatory response (13-
15). For instance, interleukin-1 (IL-1), produced mainly 
by monocytes and activated macrophages, is a potent 
proinflammatory cytokine. This interleukin is not a sin-
gle molecule, but a group that includes three different 
cytokines: IL-1α, IL-1β and the IL-1 receptor antagonist 
(IL-1Ra or IL-1RN). The latter actually functions as an 
anti-inflammatory cytokine because it binds non-pro-
ductively to the IL-1 receptor, specifically acting as a 
natural inhibitor (13-16).





















































Fig. 1: Article selection flow diagram. Adapted from: The PRISMA Group (2009). Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097.
These proteins are encoded by three different genes: 
IL1A, IL1B, and IL1RN, which make up the IL-1 gene 
cluster, located on chromosome 2 (13,14,16). At the oral 
level, several studies (15-18) have demonstrated the 
presence of high levels of IL-1α and IL-1β in crevicu-
lar fluid and in saliva of patients with active peri-im-
plantitis lesions. Moreover, it has been proven that the 
levels of these proinflammatory cytokines can even be 
reduced with treatment of the injuries. Also, it has been 
observed that with increased clinical severity or more 
advanced stage of peri-implant disease, IL-1 levels are 
higher and maintain a good correlation with parameters 
such as probing or plaque index (15-18). On the other 
hand, “de novo” plaque accumulation tests have revea-
led increased levels of IL-1 and Tumor Necrosis Factor 
(TNF), which is another proinflammatory cytokine, 30 
days after brushing was stopped and subsequent decrea-
sed levels when hygiene was restored (16).
Some functionally relevant polymorphisms in the ge-
nes that encode IL-1, under certain circumstances, can 
condition overproduction and even a basal increase 
in production of the respective cytokines (13-16). For 
example, the presence of the nucleotide Thymine (T) 
in certain polymorphic regions of IL-1A (-889), IL-1B 
(+3954) or IL-1B (-511) can lead to an increased trans-
criptional activity of the IL1A and IL1B genes, consti-
tuting “positive” or at-risk alleles. This phenomenon has 
been linked to a wide range of disorders, in which there 
is an altered inflammatory response, such as rheumatoid 
arthritis, psoriasis or inflammatory bowel disease as well 
as other pathologies (e.g., cancer) (11,12). At the oral 
level, polymorphisms of IL-1 have been widely studied 
in relation to periodontal disease (19). More recently, an 
attempt has been made to identify whether these poly-
morphisms are related to an augmented risk for early 
dental implant failure or peri-implantitis (16-18).
Polymorphisms in the IL-1 cluster are the most resear-
ched in the scientific literature in relation to peri-im-
plantitis and early implant failure. However, as we will 
analyze below, the results of these investigations have 
been somewhat contradictory. In this regard, the most 
studied polymorphic regions are IL-1A (-889), IL-1B 
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(-511) and IL-1B (+3954) (20-25). Reports related to ca-
rriers of risk SNPs with early failure or peri-implantitis 
have shown different results. Indeed, some authors have 
demonstrated a greater relative risk in carrier patients 
(10, 20-23). For instance, Cosyn et al. (20) analyzed a 
reduced sample size (14 patients with early failure and 
14 controls) and observed an increased risk of early fai-
lure in carriers of the nucleotide Thymine (T) within re-
gions of IL-1A (-889) (Odds Ratio OR = 3.9) and IL-1B 
(+3954) (OR = 15).
In an interesting study by Gruica et al. (25), analyzing 
tobacco consumption, the prevalence of biological com-
plications and the IL-1 genotype of 180 patients with 
dental implants, a statistically significant synergistic 
effect was observed between the presence of a positive 
allele and being a severe smoker with an increased risk 
of suffering from peri-implant pathology.
Notably, when these SNPs are analyzed in combination 
instead of separately, the results are even more contra-
dictory. In this regard, studies have examined the rela-
tionship between peri-implant pathology and carrying 
a combined genotype with SNPs IL-1A (-889) / IL-1B 
(+3954) or IL-1A (-889) / IL-1B (-511) / IL-1B (+3954). 
In this way, the meta-analysis conducted by Liao et al. 
(21) reported an increased risk of early failure (OR = 
1.76) and peri-implantitis (OR = 2.34) in carriers with 
both IL-1A (-889) and IL-1B (+3953) positive alleles. 
These data undergo variations when adjusted for ethnic 
origin, decreasing for Caucasians and European descen-
dants.
Given the great diversity of results in relation to IL-1 
polymorphisms, an interesting review by Bormann et al. 
(15)  divided the results obtained by different groups of 
researchers into four types: 1) those that do not find a 
statistically significant relationship between polymor-
phisms of IL-1 and peri-implantitis, 2) those concluding 
that there is an uncertain relationship, 3) those that show 
a significant relationship and 4) those that report a rela-
tionship only under the influence of certain added risk 
factors (e.g., tobacco use). Importantly, Bormann et al. 
conclude that there is a greater number of studies that 
describe a positive relationship, with or without the pre-
sence of other risk factors (15).
Recently, other authors (10,21,24) have published re-
view and meta-analysis studies. For example, Huynh-Ba 
et al. (24) suggested that there is not sufficient eviden-
ce to contradict the existence of a relationship between 
IL-1 polymorphisms and the risk of peri-implantitis. 
However, Dereka et al. (10) concluded that there is only 
a certain tendency that can be appreciated that warrants 
further study for confirmation.
-Polymorphisms of TNFα
Tumor Necrosis Factor-α (TNFα) is another key proinflam-
matory cytokine in the early stages of the inflammatory 
response (26). Similar to IL-1, elevated TNFα levels have 
been observed in crevicular fluid and saliva of patients with 
active peri-implantitis lesions and shown to directly corre-
late with the degree of clinical severity of peri-implant di-
sease (27). TNFα, among other direct and indirect effects, 
has a strong capacity to stimulate bone resorption by pro-
moting cell differentiation from the monocyte-macrophage 
line to osteoclasts, inducing the maturation of osteoclasts 
and enhancing their resorptive activity (26,27).
Several studies (26) have shown a relationship between 
polymorphisms in the TNFα region (-308) and an in-
creased susceptibility to various pathologies, including 
diabetes, coronary disease, retinopathy or polycystic 
ovarian syndrome. In relation to peri-implantitis, Rakic 
et al. (27) observed in a recent study of 369 Caucasian 
patients that the presence of the AG genotype in the 
polymorphic region of TNFα (-308) A/G was signifi-
cantly higher in individuals with peri-implant pathology, 
with the positive patients displaying five times higher 
risk for peri-implantitis. In contrast, the GG genotype 
was much more prevalent in healthy individuals and sta-
tistically conferred a certain “protective effect”.
Jacobi-Gresser et al. (22), in a retrospective evaluation 
of 109 patients, studied the relationship between the risk 
of implant failure and the presence of polymorphisms in 
the IL-1 cluster and the TNF region: IL-1A (-899) C/T, 
IL-1B (+3954) T/C, IL-1RN (+2018) T/C and TNFα 
(-308) A/G. After the genetic analysis, they detected the 
presence of the AG genotype in the polymorphic region 
of TNFα (-308) in 46.3% of the patients who had su-
ffered at least one implant failure and in 30.9% of con-
trol patients (OR = 1.9). They confirmed that subjects 
presenting a single polymorphism, from those described 
above, displayed a significantly higher risk of implant 
failure (OR = 1.57). They also observed an additive 
effect among the four polymorphisms, with carriers of 
all four alleles exhibiting the highest risk (OR = 6.01).
However, Campos et al. (28), analyzed the polymorphic 
region of TNFα (-308) A/G in a sample of 66 patients 
(28 patients who had suffered one or more failures and 
38 controls, all non-smokers) and did not find any sta-
tistically significant relationship. Gurol et al. (29), in a 
study of 95 patients (16 with early implant failure, 22 
with chronic periodontitis, 23 with healthy implants 
and 34 healthy controls), also found no significant re-
lationship between TNFα (-308) A/G and an augmented 
risk of early failure. They also obtained negative results 
when analyzing specific polymorphisms of IL-10: IL-10 
(-1082) A/G, IL-10 (-819) C/T and IL-10 (-592A/C).
Recently Mo et al. (30) performed a meta-analysis to 
clarify the controversial association between the SNP 
described above for TNFα and peri-implant pathology. 
Although they were unable to demonstrate a significant 
relationship, they suggested that further studies should 
be performed in larger patient samples to achieve defini-
tive conclusions.
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-Other polymorphisms
In the previously cited study by Rakic et al. (27) related 
to the polymorphism in the promoter region of TNFα 
(-308), the authors also analyzed the role of polymor-
phisms in the polymorphic region of CD-14 (-159) from 
the gene encoding the membrane receptor CD-14 (Clus-
ter of Diferentiation-14). CD-14 allows monocytes, 
macrophages and polymorphonuclear cells to recogni-
ze lipopolysaccharides from the wall of Gram-negative 
bacteria. The results of this study demonstrated that the 
presence of the CC genotype was associated with a five 
times greater risk of peri-implantitis, while the CT ge-
notype displayed a certain “protective effect”. They also 
found that carriers of the CC genotype had significantly 
higher concentrations of Receptor Activator of Nuclear 
Factor Kappa-Β Ligand (RANKL) in the peri-implant 
crevicular fluid.
RANKL is a key molecule for bone metabolism and is 
produced mainly by osteoblasts and fibroblasts. Upon 
binding of RANKL to its transmembrane receptor 
(RANK) it induces the resorptive capacity of osteoclasts. 
These activated osteoclasts subsequently acidify their 
environment, destabilizing the inorganic bone compo-
nent and releasing enzymes such as matrix metallopro-
teinases (MMPs) or Cathepsin K, which in turn destroy 
organic components (31).
The MMPs are a family of 24 enzymes of similar struc-
ture but different genetic origin. They are divided into 
five different groups and are responsible for the degrada-
tion of the organic components of extracellular matrix, 
both in healthy homeostasis (i.e., continuous remodeling 
of tissues) and in disease (i.e., inflammatory processes). 
MMPs display diverse activities and functions, and are 
known to participate in tumor growth, the phenomena 
of metastasis and even cellular apoptosis. In addition 
to osteoclasts, various other cell types also produce 
MMPs, including fibroblasts, epithelial cells of the gin-
gival sulcus, endothelial cells, plasma cells, monocytes/
macrophages and neutrophils. Interestingly, even some 
oral microorganisms are capable of producing MMPs 
(MMP-1) (32). The physiological activity of MMPs is 
regulated by an intricate balance between their produc-
tion and that of their antagonists, the TIMPs (Tissue In-
hibitors of MMPs). This equilibrium has been found to 
be altered during various disease states (32). 
Different authors (33,34) have observed abnormally 
high concentrations of MMPs, especially MMP-8, in the 
saliva and crevicular fluid of patients with peri-implant 
disease. Notably, a strong clinical correlation between 
the degree of peri-implant pathology and the concentra-
tion of MMP-8 was also confirmed by these studies.
Costa-Junior et al. (35) analyzed the polymorphic region 
of MMP-8 (-799) C/T in 100 healthy controls and 80 
patients who had suffered early failure of at least one 
implant. They verified that the presence of the GG geno-
type was statistically much more frequent (p = 0.0009) 
in the patient group with early failure. Therefore, they 
concluded that carriers of this genotype would have a 
higher risk of early failure.
In a group of 74 Brazilian patients (34 patients with ear-
ly failure and 40 controls), Santos et al. (36) analyzed 
the polymorphic regions of MMP-1 (-1607) and MMP-
9 (-1562) located in the promoter regions of these res-
pective genes. Regarding the first SNP, they observed 
a higher frequency of a 2G allele, with an insertion of a 
second Guanine (5’-GGA-3’), among patients who had 
suffered early failure (50%, p = 0.013). With respect to 
the second SNP in MMP-9, they did not observe statisti-
cally significant differences.
The above researchers (37,38), in an analysis of the 
same patients, could not establish statistically significant 
relationships between early failure and other polymor-
phisms in the polymorphic regions of genes encoding 
Transforming Growth Factor beta 1 (TGFβ-1), IL-2 or 
IL-6: TGFβ-1 (-509) C/T, TGFβ-1 (-800), IL-2 (-330) 
or IL-6 (-174).
Casado et al. (39) in a sample of 103 patients (also of 
Brazilian origin; 52 healthy and 51 with peri-implant/
periodontal pathology), found a positive relationship be-
tween the presence of a GG genotype in the IL-6 (-174) 
G/C region and risk of peri-implantitis. Therefore, it 
seems that the presence of the GG genotype could con-
fer a greater risk of peri-implantitis (OR: 1.43¬ - 2.03).
In contrast, Melo et al. (40), studied the same polymor-
phic region of IL-6 in 47 Brazilian patients (31 healthy 
subjects and 16 patients with peri-implantitis) without 
finding any statistically significant relationship.
In addition to the above, other polymorphisms have also 
been analyzed and are summarized in Table 1, 1 continue.
Discussion
In recent years, interest in the study of biomarkers in 
implantology has increased considerably, initially aimed 
at improving the predictability in the osseointegration 
phase of implants and more recently driven by a desire 
to reverse the increasing rates of peri-implantitis obser-
ved within the last decade (3,4). In view of the results 
that we have observed, we can confirm that this area of 
research currently remains in the developmental stages, 
with biomarkers mainly used experimentally. Although 
there is still no “commercial procedure” that allows rou-
tine clinical use, the promising initial results that have 
been published allow us to predict that in the future these 
biomarkers will be part of daily practice.
To date, the most developed biomarkers in implantology 
are the molecular and genetic biomarkers. The former is 
of great interest for the early diagnosis of peri-implan-
titis, not only to measure intensity and estimate activity, 
but also for the monitoring of both healthy and treated 
patients. In contrast, genetic biomarkers are developed 
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Rogers et al. (43) 2002 IL-1A (-899) - IF Australia 
 2002 IL-1A (+3953) - IF Australia 
Feloutzis et al. (44) 2003 IL-1A (-899) + (smokers) MBL Switzerland. 
 2003 IL-1A (+3954)) + (smokers) MBL Switzerland. 
Shimpuku et al. (45) 2003 IL-1A (-889) - MBL Japan 
 2003 IL-1B (+3954) - MBL Japan 
 2003 IL-1B (-511) + MBL Japan 
Santos et al. (36) 2004 MMP-1 (-1607) + EIF Brasil 
 2004 MMP-9 (-1562) - EIF Brasil 
Dos Santos et al. (37) 2004 TGF-β1 (-509) - EIF Brasil 
 2004 TGF-β1 (-800) - EIF Brasil 
Gruica et al. (25) 2004 IL-1A (+4845) + (smokers) PI Switzerland 
 2004 IL-1B (+3954) + (smokers) PI Switzerland 
Jansson et al. (46) 2005 IL-1A (-889) + (smokers) EIF Sweden 
 2005 IL-1B (+3953) + (smokers) EIF Sweden 
Campos et al. (28) 2004 TNFα (-308) + EIF Brasil 
Campos et al. (38) 2005 IL-2 (-330) - EIF Brasil 
 2005 IL-6 (-174) - EIF Brasil 
Campos et al. (47) 2005 IL-1A (-889) - EIF Brasil 
 2005 IL-1B (+3953) - EIF Brasil 
 2005 IL-1RN (intron 2) - EIF Brasil 
De Boever et al. (48) 2006 Il-1A (-889) - MBL Belgium 
 2006 Il-1B (+3953) - MBL Belgium 
Laine et al. (49) 2006 IL 1A (-899) + PI The Netherlands 
 2006 IL 1B (+3953) + PI The Netherlands 
 2006 IL 1B (+) + PI The Netherlands 
Cury et al. (50) 2007 TNF-α (-308) - MBL Brasil 
Lachmann et al. (51)  2007 IL 1A (-899) - PI Germany 
 2007 IL 1B (+3953) - PI Germany 
Alvim-Pereira et al. (52) 2008 VDR (rs731236, TaqI) - IF Brasil 
Lin et al. (53) 2008 IL-1A (-889) - EIF China 
 2008 IL-1B (+3953) - EIF China 
 2008 IL-1B (-511) + EIF China 
Jaworska-Zaremba et al. (54) 2008 IL-1A (-889) - MBL Polonia 
 2008 IL-1B (+3953) + PI Polonia 
 2008 IL-1B (-511) + MBL Polonia 
Leite et al. (55) 2008 MMP-1 (-1607) + EIF Brasil 
 2008 MMP-1 (-519) - EIF Brasil 
Cury et al. (56) 2009 TNF-α (-308) - PI Brasil 
Montes et al. (57) 2009 IL-1B (+3954) + IF Brasil 
Table 1: Summary of polymorphisms studied in relation to dental implants biological complications. IF: Implant loss, EIF: Early Implant Fail-
ure, PI: Peri-implantitis, MBL: Marginal Bone Loss.
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 2009 IL-1RN (intron 2) + IF Brasil 
Dirschnabel et al. (9) 2011 IL-1B (-511) - IF Brasil 
Hamdy et al. (23) 2011 IL-1A (-889) + PI Egypt 
 2011 IL-1B (+3953) + PI Egypt 
Gurol et al. (29) 2011 TNF-α (-308) - EIF Turkey 
Melo et al. (40)  2012 IL-6 (-174) - PI Brasil 
 2012 IL-1B (+3954) - PI Brasil 
 2012 IL-1B (-511) - PI Brasil 
Kadkhodazadeh et al.(58) 2012 OPG (T950C) - PI Iran 
 2012 OPG (G1181C) + PI Iran 
Kadkhodazadeh et al. (59) 2012 IKKI (rs1539243) + PI Iran 
Vaz et al. (60) 2012 IL-1A (-889) + IF Portugal 
 2012 IL-1A (+3954)) + IF Portugal 
Kadkhodazadeh et al. (61) 2012 TANK  (rs1921310) - PI Iran 
 2012 TANK  ( rs3820998) - PI Iran 
Jacobi-Gresser et al. (22) 2013 IL-1A (-889) + IF Germany 
 2013 IL-1B (+3954) + IF Germany 
 2013 IL-RN  (+2018) + IF Germany 
 2013 TNF-α (-308) + IF Germany 
Kadkhodazadeh et al. (62) 2013 IL-17R (rs879576) - PI Iran 
Kadkhodazadeh et al. (63) 2013 IL-17 (rs10484879) + PI Iran 
Kadkhodazadeh et al.(64) 2013 RANKL (rs9533156) + PI Iran 
 2013 RANKL(rs2277438) - PI Iran 
Costa-Junior et al. (35) 2013 MMP-8 (-799) + EIF Brasil 
Kadkhodazadeh et al.(65) 2013 MiR146a (rs2910146) + PI Iran 
 2013 MiR499 (rs3746444) + PI Iran 
Kadkhodazadeh et al.(66) 2013 B-RAF (rs10487888) - PI Iran 
Casado et al. (39) 2013 IL-6 (-174) + PI Brasil 
Ebadian et al.(67) 2014 Hp-Hb (haptoglobin-
hemoglobin) complex 
- PI Iran 
Rakic et al. (27) 2014 CD-14 (-159) + PI Serbia 
 2014 TNF-α (-308) + PI Serbia 
Pigossi et al. (68) 2014 IL4 (-590) - IF Brasil 
 2014 IL4 (+33) + IF Brasil 
Zhou et al.  (69) 2016 OPG  T950C (rs2073617) - PI China 
 2016 OPG G1181C (rs2073618) + PI China 
Cosyn et al. (20) 2016 IL 1A (-889) + EIF Belgium 
 2016 IL 1A (-511) + EIF Belgium 
 2016 IL 1A (+3954) + EIF Belgium 
Ribeiro et al. (70) 2017 IL-10 (-1082) - IF Brasil 
 2017 RANKL (-438) - IF Brasil 
Petkovic-Curcin et al. (71) 2017 TNFα (-308) (en fumadores) + PI Serbia 
 2017 CD14 (-159) - PI Serbia 
	
Table 1 continue: Summary of polymorphisms studied in relation to dental implants biological complications. IF: Implant loss, EIF: Early 
Implant Failure, PI: Peri-implantitis, MBL: Marginal Bone Loss.
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for another purpose: to estimate the relative risk of an 
individual to suffer from peri-implantitis owing to their 
own innate characteristics. Irrespective of the presence 
of certain known risk factors associated with peri-im-
plantitis, studies have tried to analyze statistically whe-
ther carrying certain “genetic peculiarities”, such as 
polymorphisms, could confer a higher relative risk of 
experiencing peri-implantitis (6-8).
Functionally relevant polymorphisms in genes that con-
trol expression of molecules regulating bone physiology 
and inflammatory response, for the most part, condition 
the overexpression of these genes. For this reason, they 
are also responsible for a dysregulated physiological res-
ponse, especially under the action of known etiological 
factors for peri-implantitis. In line with this, these poly-
morphisms could then enhance the action of known risk 
factors, such as tobacco consumption, poor hygiene, the 
use of an inadequate prosthesis, etc. In example, poly-
morphisms might interact with the actions of known risk 
factors from a pathogenic point of view by contributing 
to breakage of the balance between the oral biofilm and 
the immune system, to disruption of the equilibrium be-
tween microfractures caused by occlusal forces transmi-
tted to maxillary bones and the capacity for bone rege-
neration, or to increased corrosion of the implant surface 
layer. All of these phenomena are not fully understood 
and are surrounded by certain gaps in knowledge that 
require future clarification (6-8). 
Knowing in advance the relative “innate” risk of a patient 
to experience peri-implantitis, based on the detection of 
specific polymorphisms, would allow improvement or mo-
dification in the criteria for therapeutic indication. This in-
formation could also be used to “customize” and optimize 
monitoring and control protocols, or even make the treat-
ment and therapeutic protocol selection more objective.
For most of the relevant articles available in the scienti-
fic literature a single polymorphism was analyzed. These 
studies attempted to standardize the samples and reduce 
possible biases, while examining in a statistically signi-
ficant way, whether the presence of a specific genotype 
was more prevalent among individuals with biological 
complications compared to healthy patients. We found 
that the results are often contradictory between the diffe-
rent study groups. The specific methodologies utilized, 
and especially the criteria for patient selection, are criti-
cal points that might have resulted in such discrepancies. 
Several authors (10,21,24) have performed meta-analy-
ses to try to shed light on the observed differences. The-
se investigations identified that the number of studies 
available with a high level of scientific evidence is very 
small. In fact, many are preliminary studies with a low 
level of evidence or displaying methodological shortco-
mings, especially with regard to the uniformity of the 
study groups. Altogether, these factors make it difficult 
to come to definitive conclusions.
Many of the studies performed to analyze the relations-
hip between biological complications in implantology 
and genetic polymorphisms are based on other similar 
investigations in relation to periodontitis (41). Undoub-
tedly, there are many similarities between natural teeth 
and implants, but there are also many aspects that are 
critically different, and of course these distinctions could 
specifically impact on this field. In this regard, a detailed 
review of the literature will allow us to verify how many 
of the relationships observed in periodontal pathology, 
either have not been found in studies on implantology or 
were not yet tested in relation to implants.
Another critical point that should be remembered when 
comparing studies and analyzing the importance of a 
certain genetic polymorphism, is that the ethnic origin of 
the study population must always be taken into account, 
since the prevalence of such polymorphisms in the gene-
ral population can vary substantially. For example, some 
of the polymorphisms cited in relation to the IL-1 cluster 
are present in greater than one third of the population in 
Caucasians (41,42), but do not exceed 3% among Asian 
patients (42).
For advancing knowledge in this area of implantology, 
there is a fundamental need for new research. Among 
others, the main criticisms that we can draw from the 
meta-analyses and reviews existing in the literature in 
relation to some of the preliminary studies include: the 
shortage of prospective works, the reduced number of 
patients, the short or unspecified period of follow-up of 
patients or the lack of control with regard to systemic 
pathologies of interest (10,21,24). These points should 
be taken into account when designing future studies. 
Moreover, key points to consider in order to avoid bia-
ses should be the control of the ethnic origin of the pa-
tients as well as other risk factors experienced by the 
study group (not only tobacco consumption). Above all, 
although it requires an enormous effort, the sample ho-
mogenization should be tightly controlled (i.e., by type 
of treatment, types of implants, auxiliary surgical tech-
niques used, location of implants, etc.).
In addition, given the high prevalence in the population 
of some of the polymorphisms cited throughout this 
work, it would be of great interest to study various poly-
morphisms in the same individual (considering a very 
large sample size) and not only analyze single polymor-
phisms. Although it is true that this would represent an 
enormous task, it could allow analysis of multivariable 
statistics and identify if there are summative or even 
synergistic effects between different types of polymor-
phisms.
Likewise, new studies are needed to measure the syner-
gistic effect already observed by some authors (21,25) 
between polymorphisms and other risk factors, especia-
lly the consumption of tobacco.
An excellent option to discover new polymorphisms as-
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sociated with peri-implant pathology, would be the rea-
lization of a Genome-Wide Association Study (GWAS) 
using large samples of multiethnic origin and “extreme 
genotypes”. Within these extreme genotypes it would be 
very interesting to include, among others, patients who 
have suffered what some authors have termed a “cluster 
failure”.
Conclusions
There are few studies that have attempted to relate the 
presence of certain polymorphisms with a higher risk of 
early implant failure and/or peri-implantitis. The most 
studied polymorphisms are the SNPs. Among those that 
have shown a statistically significant relationship, there 
are some SNPs identified within the coding regions of 
genes, including mediators of inflammatory responses 
as well as molecules participating in physiological bone 
remodeling processes.
Based on available research and the current level of 
understanding regarding the relationship between poly-
morphisms for early failure or peri-implantitis, a reliable 
and/or reproducible genetic biomarker of risk has not yet 
been identified that could be used in the general popu-
lation or commercialized. However, many authors agree 
that this is a field that warrants deeper investigation. Gi-
ven the positive results of some preliminary investiga-
tions, new studies are needed that employ larger sample 
sizes and stringent methodologies in order to minimize 
the lack of uniformity and bias.
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